共 285 条
[1]
Musunuru K(2016)Surprises from genetic analyses of lipid risk factors for atherosclerosis Circ Res 118 579-585
[2]
Kathiresan S(2005)Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins Lancet 366 1267-78
[3]
Baigent C(2018)Increased cardiovascular risk in hypertriglyceridemia patients with statin-controlled LDL cholesterol J Clin Endocrinol Metab 103 3019-3027
[4]
Keech A(2020)Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridemia Eur Heart J 41 3936-3945
[5]
Kearney PM(2016)Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology Circ Res 118 547-563
[6]
Blackwell L(2021)Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies–a consensus statement from the European Atherosclerosis Society Eur Heart J 42 4791-4806
[7]
Buck G(2022)A tale of two new targets for hypertriglyceridemia: which choice of therapy? BioDrugs 36 121-135
[8]
Pollicino C(2019)GPIHBP1 and lipoprotein lipase, partners in plasma triglyceride metabolism Cell Metab 30 51-65
[9]
Nichols GA(2010)GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries Cell Metab 12 42-52
[10]
Philip S(2009)Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis Biochem Biophys Res Commun 379 806-811